Proteins of the innate immune system crystallize on carbon nanotubes but are not activated.

The classical pathway of complement is an essential component of the human innate immune system involved in the defense against pathogens as well as in the clearance of altered self-components. Activation of this pathway is triggered by C1, a multimolecular complex comprising a recognition protein C1q associated with a catalytic subunit C1s-C1r-C1r-C1s. We report here the direct observation of organized binding of C1 components C1q and C1s-C1r-C1r-C1s on carbon nanotubes, an ubiquitous component in nanotechnology research. Electron microscopy imaging showed individual multiwalled carbon nanotubes with protein molecules organized along the length of the sidewalls, often over 1 μm long. Less well-organized protein attachment was also observed on double-walled carbon nanotubes. Protein-solubilized nanotubes continued to attract protein molecules after their surface was fully covered. Despite the C1q binding properties, none of the nanotubes activated the C1 complex. We discuss these results on the adsorption mechanisms of macromolecules on carbon nanotubes and the possibility of using carbon nanotubes for structural studies of macromolecules. Importantly, the observations suggest that carbon nanotubes may interfere with the human immune system when entering the bloodstream. Our results raise caution in the applications of carbon nanotubes in biomedicine but may also open possibilities of novel applications concerning the many biochemical processes involving the versatile C1 macromolecule.

[1]  Dirk M. Guldi,et al.  Carbon nanotubes--electronic/electrochemical properties and application for nanoelectronics and photonics. , 2009, Chemical Society reviews.

[2]  P. Tacnet-Delorme,et al.  C1q Binds Phosphatidylserine and Likely Acts as a Multiligand-Bridging Molecule in Apoptotic Cell Recognition1 , 2008, The Journal of Immunology.

[3]  J. Cesbron,et al.  Complement Protein C1q Forms a Complex with Cytotoxic Prion Protein Oligomers , 2010, The Journal of Biological Chemistry.

[4]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[5]  G. Grüner,et al.  Charge Transfer from Adsorbed Proteins , 2004 .

[6]  R A Milligan,et al.  Helical processing using PHOELIX. , 1996, Journal of structural biology.

[7]  K. Reid,et al.  Subunit composition and structure of subcomponent C1q of the first component of human complement. , 1976, The Biochemical journal.

[8]  V. Weiss,et al.  Functional model of subcomponent C1 of human complement. , 1986, Journal of molecular biology.

[9]  R. Ziccardi The first component of human complement (C1): Activation and control , 2004, Springer Seminars in Immunopathology.

[10]  T. Ebbesen,et al.  Supramolecular Self-Assembly of Lipid Derivatives on Carbon Nanotubes , 2003, Science.

[11]  R. Stroud,et al.  Ultrastructure of the Human Complement Component, Clq , 1972 .

[12]  A Leith,et al.  SPIDER and WEB: processing and visualization of images in 3D electron microscopy and related fields. , 1996, Journal of structural biology.

[13]  G. Schoehn,et al.  Two-chaperone assisted soluble expression and purification of the bacteriophage T4 long tail fibre protein gp37. , 2010, Protein expression and purification.

[14]  M. Dobrovolskaia,et al.  Immunological properties of engineered nanomaterials , 2007, Nature Nanotechnology.

[15]  Maurizio Prato,et al.  Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. , 2003, Chemistry & biology.

[16]  H. Dai,et al.  Carbon nanotubes as intracellular protein transporters: generality and biological functionality. , 2005, Journal of the American Chemical Society.

[17]  B. Xing,et al.  Adsorption mechanisms of organic chemicals on carbon nanotubes. , 2008, Environmental science & technology.

[18]  Gérard J Arlaud,et al.  Modified low density lipoproteins differentially bind and activate the C1 complex of complement. , 2007, Molecular immunology.

[19]  P. Taylor,et al.  A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo , 2000, The Journal of experimental medicine.

[20]  Malcolm L. H. Green,et al.  Binding of pulmonary surfactant proteins to carbon nanotubes; potential for damage to lung immune defense mechanisms , 2007 .

[21]  Edward H Egelman,et al.  The iterative helical real space reconstruction method: surmounting the problems posed by real polymers. , 2007, Journal of structural biology.

[22]  H. Dai,et al.  In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. , 2020, Nature nanotechnology.

[23]  Robert B Sim The first component of human complement , 1976 .

[24]  P. Gasque,et al.  Activation of Complement in the Central Nervous System , 2003, Annals of the New York Academy of Sciences.

[25]  Koji Yonekura,et al.  GUI programs for processing individual images in early stages of helical image reconstruction--for high-resolution structure analysis. , 2003, Journal of structural biology.

[26]  T. Ebbesen,et al.  Helical Crystallization of Proteins on Carbon Nanotubes: A First Step towards the Development of New Biosensors. , 1999, Angewandte Chemie.

[27]  T. Webster,et al.  Greater osteoblast functions on multiwalled carbon nanotubes grown from anodized nanotubular titanium for orthopedic applications , 2007 .

[28]  N. Thielens,et al.  Identification of the C1q-binding Sites of Human C1r and C1s , 2009, The Journal of Biological Chemistry.

[29]  Robert B Sim,et al.  Differential elution of Clq, Clr and Cls from human Cl bound to immune aggregates. Use in the rapid purification of Cl subcomponents. , 1979, Molecular immunology.

[30]  Robert B Sim,et al.  C1q and tumor necrosis factor superfamily: modularity and versatility. , 2004, Trends in immunology.

[31]  P. Tacnet-Delorme,et al.  β-Amyloid Fibrils Activate the C1 Complex of Complement Under Physiological Conditions: Evidence for a Binding Site for Aβ on the C1q Globular Regions1 , 2001, The Journal of Immunology.

[32]  P. Tran,et al.  Carbon nanofibers and carbon nanotubes in regenerative medicine. , 2009, Advanced drug delivery reviews.

[33]  Malcolm L. H. Green,et al.  Complement activation and protein adsorption by carbon nanotubes. , 2006, Molecular immunology.

[34]  M. Cicardi,et al.  Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.

[35]  G. Arlaud,et al.  Purified proenzyme C1r. Some characteristics of its activation and subsequent proteolytic cleavage. , 1980, Biochimica et biophysica acta.

[36]  Nastassja A. Lewinski,et al.  Cytotoxicity of nanoparticles. , 2008, Small.

[37]  N. Thielens,et al.  Structure and activation of the C1 complex of complement: unraveling the puzzle. , 2004, Trends in immunology.

[38]  M. Shim,et al.  Noncovalent functionalization of carbon nanotubes for highly specific electronic biosensors , 2003, Proceedings of the National Academy of Sciences of the United States of America.